Cover Image

Increased body mass index linked to decreased neutralizing antibody titers of inactivated SARS‐CoV‐2 vaccine in healthcare workers

Abstract Objective Obesity is an important risk factor for COVID‐19. However, whether obesity affects SARS‐CoV‐2 antibody production is unclear. This study aimed to identify the influence of obesity on neutralizing antibody production of an inactivated SARS‐CoV‐2 vaccine to better guide vaccination...

Full description

Saved in:

Bibliographic Details
Main Authors:	Juan Hu (Author), Mingcai Zhao (Author), Yongmei Zhao (Author), Wenjuan Dong (Author), Xuemei Huang (Author), Shaocheng Zhang (Author)
Format:	Book
Published:	Wiley, 2023-02-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Neutralization antibody titers against SARS-CoV-2 in an infant born to a mother with COVID-19
by: Yi-Ching Chen, et al.
Published: (2021)

Neutralizing Antibody Response by Inactivated SARS-CoV-2 Vaccine on Healthcare Workers
by: Nataniel Tandirogang, et al.
Published: (2023)

The Quality of Anti-SARS-CoV-2 T Cell Responses Predicts the Neutralizing Antibody Titer in Convalescent Plasma Donors
by: Marie Kroemer, et al.
Published: (2022)

Neutralizing and enhancing antibodies against SARS-CoV-2
by: Yafei Liu, et al.
Published: (2022)

Long-term observation of antibody titers against SARS-CoV-2 following vaccination
by: Kazuo Sugiyama, et al.
Published: (2022)

The predictors of high titer of anti-SARS-CoV-2 antibody of convalescent plasma donors
by: Shinta Oktya Wardhani, et al.
Published: (2021)

Effect of treatment with original or biosimilar adalimumab on SARS-CoV2 vaccination antibody titers
by: Eva Dokoupilová, et al.
Published: (2024)

Correlation between anti-S IgG and neutralizing antibody titers against three live SARS-CoV-2 variants in BNT162b2 vaccine recipients
by: Yuki Higashimoto, et al.
Published: (2022)

Neutralizing antibody titers over 12 months after SARS-CoV-2 mRNA vaccine booster in patients with relapsing multiple sclerosis continuously treated with ofatumumab
by: Tjalf Ziemssen, et al.
Published: (2024)

Fourth mRNA vaccination increases cross-neutralizing antibody titers against SARS-CoV-2 variants, including BQ.1.1 and XBB, in a very elderly population
by: Silvia Sutandhio, et al.
Published: (2023)

Anti-SARS-CoV-2 neutralizing monoclonal antibodies: clinical pipeline
by: Marco Tuccori, et al.
Published: (2020)

Pneumococcal Antibody Titers
by: Pamella F. Abghari MD, et al.
Published: (2017)

Analysis of cross-reactive antibodies recognizing the fusion loop of envelope protein and correlation with neutralizing antibody titers in Nicaraguan dengue cases.
by: Chih-Yun Lai, et al.
Published: (2013)

Potent SARS-CoV-2 binding and neutralization through maturation of iconic SARS-CoV-1 antibodies
by: Romain Rouet, et al.
Published: (2021)

Impact of SARS-CoV-2 Resistance to Antiviral Monoclonal Antibody Therapy on Neutralizing Antibody Response
by: Marc-Kendy Paul, et al.
Published: (2024)

The Screening of Broadly Neutralizing Antibodies Targeting the SARS-CoV-2 Spike Protein by mRNA Immunization in Mice
by: Zhiyin An, et al.
Published: (2023)

Effect of difference between EV-A71 virus epidemic strain and "vaccine strain" on neutralizing antibody titer
by: Yiwei Ding, et al.
Published: (2022)

The importance of RSV F protein conformation in VLPs in stimulation of neutralizing antibody titers in mice previously infected with RSV
by: Lori M. Cullen, et al.
Published: (2017)

Factors Associated with SARS-CoV-2 Antibody Titer After Sinovac Vaccination Among Health Care Workers
by: Theresia Santi, et al.
Published: (2022)

Binding and neutralizing abilities of antibodies towards SARS-CoV-2 S2 domain
by: Xingsu Gao, et al.
Published: (2022)

Emerging SARS-CoV-2 variants: impact on vaccine efficacy and neutralizing antibodies
by: Khan Sharun, et al.
Published: (2021)

Neutralizing antibody response elicited by SARS-CoV-2 receptor-binding domain
by: Ping-Han Huang, et al.
Published: (2021)

Comprehensive engineering of a therapeutic neutralizing antibody targeting SARS-CoV-2 spike protein to neutralize escape variants
by: Taichi Kuramochi, et al.
Published: (2022)

Developability profiling of a panel of Fc engineered SARS-CoV-2 neutralizing antibodies
by: Andrew Dippel, et al.
Published: (2023)

Neutralizing and cross-reacting antibodies: implications for immunotherapy and SARS-CoV-2 vaccine development
by: Samuel A. Cohen, et al.
Published: (2021)

Evaluation of antibody responses in healthy individuals receiving SARS-CoV-2 inactivated vaccines
by: Ziyu Liu, et al.
Published: (2024)

Prediction of serum HIV-1 neutralization titers of VRC01 in HIV-uninfected Antibody Mediated Prevention (AMP) trial participants
by: Yunda Huang, et al.
Published: (2022)

VITT with inactivated SARS-CoV-2 vaccine - index case
by: Kanta Devi, et al.
Published: (2022)

Bispecific VH/Fab antibodies targeting neutralizing and non-neutralizing Spike epitopes demonstrate enhanced potency against SARS-CoV-2
by: Shion A. Lim, et al.
Published: (2021)

Characterization of MW06, a human monoclonal antibody with cross-neutralization activity against both SARS-CoV-2 and SARS-CoV
by: Wen Jiang, et al.
Published: (2021)

Antibody titers and rapid antigen testing in elderly patients with SARS-CoV-2 pneumonia vs. staff of ICU and "Covid-19" wards
by: Epstude, Jörg, et al.
Published: (2021)

Supercritical Carbon Dioxide Extract of Seabuckthorn Leaves Enhances Rabies Virus Neutralizing Antibody Titers and CTL Response in Swiss Albino Mice
by: B Jayashankar, et al.
Published: (2016)

Symptoms, SARS-CoV-2 Antibodies, and Neutralization Capacity in a Cross Sectional-Population of German Children
by: Otto Laub, et al.
Published: (2021)

Neutralizing antibodies in milk and blood of lactating women vaccinated for SARS-CoV-2: a systematic review
by: Ianne Stéfani Angelim Vieira, et al.
Published: (2024)

Reduced antibody response to COVID-19 vaccine composed of inactivated SARS-CoV-2 in diabetic individuals
by: Yandong Cheng, et al.
Published: (2022)

The serological IgG and neutralizing antibody of SARS-CoV-2 omicron variant reinfection in Jiangsu Province, China
by: Jinjin Chu, et al.
Published: (2024)

Rapid discovery of diverse neutralizing SARS-CoV-2 antibodies from large-scale synthetic phage libraries
by: Tom Z. Yuan, et al.
Published: (2022)

Resistance of SARS-CoV-2 Delta variant to neutralization by BNT162b2-elicited antibodies in Asians
by: Bei Wang, et al.
Published: (2021)

Computational design of a neutralizing antibody with picomolar binding affinity for all concerning SARS-CoV-2 variants
by: Bo-Seong Jeong, et al.
Published: (2022)

Finger stick blood test to assess postvaccination SARS‐CoV‐2 neutralizing antibody response against variants
by: Sing Mei Lim, et al.
Published: (2022)